Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$0

Karyopharm Therapeutics Inc. (KPTI) Class Action Lawsuit (July 2019)

Closed

21-1657 • July 23, 2019

Class Period Start

March 2, 2017

Class Period End

February 22, 2019

PSLRA Deadline

September 23, 2019

Case Allegations

10b5 + Sec11

10b-5 Statutes of Repose

Mar 2, 2020

Sec11 Statutes of Repose

Apr 28, 2020

Country

United States

Court

Federal Court

Docket History

Jul 21, 2021

Motion to Dismiss Granted (opens in a new tab)

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Nov 2, 2020

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Oct 22, 2020

Second Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in Karyopharm Therapeutics Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

View all Updates